IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GRISANTI, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.905
EU - Europa 2.031
AS - Asia 919
AF - Africa 14
SA - Sud America 6
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.883
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.879
CN - Cina 467
UA - Ucraina 417
PL - Polonia 364
IT - Italia 343
DE - Germania 285
HK - Hong Kong 211
FI - Finlandia 179
SG - Singapore 140
IE - Irlanda 130
GB - Regno Unito 86
FR - Francia 73
CZ - Repubblica Ceca 51
SE - Svezia 37
IN - India 34
VN - Vietnam 32
CA - Canada 26
BE - Belgio 22
JP - Giappone 15
RU - Federazione Russa 13
NL - Olanda 8
GR - Grecia 6
CH - Svizzera 5
IR - Iran 5
AU - Australia 4
MU - Mauritius 4
AZ - Azerbaigian 3
BR - Brasile 3
EG - Egitto 3
EU - Europa 3
MA - Marocco 3
PT - Portogallo 3
TR - Turchia 3
CL - Cile 2
NO - Norvegia 2
TH - Thailandia 2
TW - Taiwan 2
ZA - Sudafrica 2
ZW - Zimbabwe 2
CY - Cipro 1
EE - Estonia 1
ES - Italia 1
FK - Isole Falkland (Malvinas) 1
IS - Islanda 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
SI - Slovenia 1
Totale 7.883
Salva come PNG Salva come JPEG
Città #
Fairfield 746
Woodbridge 532
Ashburn 439
Houston 383
Warsaw 364
Jacksonville 308
Cambridge 305
Seattle 303
Chandler 301
Wilmington 246
Hong Kong 209
Princeton 178
Ann Arbor 166
New York 149
Helsinki 141
Dublin 98
Beijing 89
Nanjing 86
Singapore 84
Boardman 70
Brescia 60
Shanghai 58
Dearborn 50
Brno 42
San Diego 35
Des Moines 34
Milan 34
Munich 34
Nanchang 34
Dong Ket 32
Los Angeles 31
Changsha 29
Washington 27
West Jordan 26
Shenyang 25
Brussels 22
Menlo Park 22
Lancaster 21
Jinan 19
Dalmine 18
Tianjin 17
Hebei 16
Naples 16
Toronto 16
London 15
San Francisco 13
Vignate 12
Hangzhou 11
Jiaxing 10
Pune 10
Verona 10
Guangzhou 9
Gumyojicho 9
Haikou 9
Kunming 9
Ningbo 9
Olomouc 9
Taizhou 9
Zhengzhou 8
Chicago 7
Falls Church 7
Lanzhou 7
Redwood City 7
Rome 7
Athens 6
Cazzago San Martino 6
Fukuoka 6
Leawood 6
Livorno 6
Turin 6
Lappeenranta 5
Perugia 5
Falkenstein 4
Gunzenhausen 4
New Bedfont 4
North York 4
Norwalk 4
Ottawa 4
Phoenix 4
San Mateo 4
Ventimiglia 4
Ardabil 3
Augusta 3
Borås 3
Chiswick 3
Dietikon 3
Gardone Val Trompia 3
Kocaeli 3
Melbourne 3
Nürnberg 3
Orange 3
Rio De Janeiro 3
Rockville 3
Santa Clara 3
Solbiate Olona 3
Treviglio 3
Villa Di Tirano 3
Acton 2
Beinasco 2
Bergamo 2
Totale 6.238
Salva come PNG Salva come JPEG
Nome #
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 180
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy 172
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 165
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 162
Immunotherapy failure in adrenocortical cancer: where next? 157
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 145
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 144
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 144
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 142
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 140
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 140
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 139
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 139
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 135
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 127
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 124
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 118
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 117
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 114
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 112
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 111
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer? 111
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 110
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 109
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 108
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 106
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. 106
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 102
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 102
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 101
Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial Update 101
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 100
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 100
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 99
Idiopathic intracranial hypertension: A possible complication in the natural history of advanced prostate cancer. 96
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial 94
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 93
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 93
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 92
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 91
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 90
Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG) 90
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 90
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 90
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 88
Aspergillosis superinfection as a cause of death of crizotinib-induced interstitial lung disease successfully treated with high-dose corticosteroid therapy 86
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 84
Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. 83
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 83
Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma 82
An alternating regimen of irinotecan/ 5-fluorouracil/folinic acid and oxaliplatin/ 5-fluorouracil/folinic acid in metastatic colorectal cancer: a Phase II trial 80
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 79
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 77
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 76
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 69
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 69
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 64
Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma 62
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? 56
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 55
Dynamic Susceptibility Contrast MR Imaging inGlioblastomas: Correlation of Whole-TumorHistogram Analysis of the Normalized CerebralBlood Volume and Vascular Permeability withHistopathologic and Molecular Markers of TumorAggressiveness 54
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies 53
TOPOIIalpha and HER-2/neu overexpression/amplification in Barrett's oesophagus, dysplasia and adenocarcinoma 50
Targeted therapy with trastuzumab in dysplasia and adenocarcinoma arising in Barrett’s esophagus: a traslational approach 49
Topo IIα and HER-2/neu Overexpression/Amplification in Barrett's Esophagus, Dysplasia and Adenocarcinoma 49
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 48
Comparison of the prognostic classification with recursive partitioning analysis (RPA) and general prognostic assessment (GPA) in a retrospective analysis of 430 patients with brain metastases 47
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 47
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 46
Targeted therapy with trastuzumab in Barrett’s dysplasia and adenocarcinoma: a translational approach 46
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs 46
Retrospective analysis of 107 patients whit localized extranodal limphoma of the head and neck treated with radiotherapy alone or combined modality treatment: final analysis of response rate, survival and pattern of relapse 45
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 44
HER-2 overexpression/amplification in esophageal dysplasia predicts early transition to adenocarcinoma: a clinico-pathologic study 43
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 43
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 41
HER-2/neu in Barrett’s esophagus: immunohistochemistry and fluorescence in situ hybridization (FISH) to identify a new subgroup of patients. 40
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 40
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 39
Could a comprehensive urinary endogenous steroidal profile improve the accuracy of prostate-specific antigen screening? 37
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 36
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 35
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 34
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs 32
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 32
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 30
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 29
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 28
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative study 27
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 26
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 26
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 25
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases 25
Is BMI a reliable prognostic parameter in metastatic prostate cancer patients? 24
Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases 22
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 21
Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation 21
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 21
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 20
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 20
Totale 7.835
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.307
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.719 0 63 72 210 138 225 200 217 177 206 85 126
2020/20211.656 52 175 110 216 103 173 52 171 150 214 123 117
2021/2022848 67 82 30 96 22 53 36 56 43 108 64 191
2022/2023823 106 53 42 63 70 191 5 74 119 22 44 34
2023/20241.474 71 41 133 93 104 269 46 79 226 69 49 294
2024/202591 50 41 0 0 0 0 0 0 0 0 0 0
Totale 8.128